http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018016806-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7aab41d5b2f11e22377b7628d3e9f5d3 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-465 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-01023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-18 |
| filingDate | 2017-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_521eac8f1ae9a1b509eb0f83876fe453 |
| publicationDate | 2018-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2018016806-A1 |
| titleOfInvention | Method for treatment of liver steatosis or non-alcoholic fatty liver by using 2-monoacylglycerol cleaving enzyme |
| abstract | The present invention relates to a method for treatment of liver steatosis or non-alcoholic fatty liver by using 2-monoacylglycerol cleaving enzyme, and more particularly provides a method for treatment of metabolic syndrome, such as liver steatosis, non-alcoholic fatty liver, hyperlipidemia, type 2 diabetes, and/or obesity, in which a 2-monoacylglycerol cleaving enzyme is used to completely digest triacylglycerides into fatty acids and glycerols in a digestive tract to delay fat absorption and to reduce the uptake of blood triacylglycerides and in which when digested with monoacylglycerol lipase in the digestive tract, monoacylglycerol, although absorbed, is delayed to recombine into triacylglycerides in epithelial cells of the digestive tract or energy consumption for this process is promoted. |
| priorityDate | 2016-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 357.